What is she best known for?
The fields of study she is best known for:
- Virus
- Immune system
- Antibody
Anna P. Durbin mainly focuses on Virology, Dengue virus, Dengue fever, Immunology and Dengue vaccine.
As part of one scientific family, she deals mainly with the area of Virology, narrowing it down to issues related to the Immunogenicity, and often Plasmodium falciparum.
In Dengue virus, she works on issues like Epitope, which are connected to Monoclonal antibody, Vero cell, Infectivity, Humoral immunity and Viral entry.
Her Dengue fever research is multidisciplinary, relying on both T cell and Serotype.
Her Dengue vaccine research is multidisciplinary, incorporating elements of Viremia and Disease.
Her research investigates the connection between Antigen and topics such as Antibody that intersect with issues in Viral life cycle.
Her most cited work include:
- Prospects for a dengue virus vaccine. (477 citations)
- Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51 (340 citations)
- Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region. (263 citations)
What are the main themes of her work throughout her whole career to date?
Anna P. Durbin mostly deals with Virology, Dengue virus, Dengue fever, Immunology and Dengue vaccine.
Anna P. Durbin studied Virology and Antibody that intersect with Immunity.
Her studies in Dengue virus integrate themes in fields like Neutralizing antibody, Viremia, T cell, Epitope and Monoclonal antibody.
Her work deals with themes such as DNA vaccination, Disease, Immunodominance and Environmental health, which intersect with Dengue fever.
Her Vaccination, Immunogenicity, Antigen and Plasmodium falciparum study, which is part of a larger body of work in Immunology, is frequently linked to CpG site, bridging the gap between disciplines.
Her work carried out in the field of Dengue vaccine brings together such families of science as Clinical trial, Immune system and Intensive care medicine.
She most often published in these fields:
- Virology (70.54%)
- Dengue virus (57.14%)
- Dengue fever (54.46%)
What were the highlights of her more recent work (between 2018-2021)?
- Dengue virus (57.14%)
- Virology (70.54%)
- Dengue vaccine (45.54%)
In recent papers she was focusing on the following fields of study:
Her main research concerns Dengue virus, Virology, Dengue vaccine, Dengue fever and Vaccination.
To a larger extent, she studies Immunology with the aim of understanding Dengue virus.
Anna P. Durbin usually deals with Virology and limits it to topics linked to Immunodominance and Infectivity.
Her research integrates issues of Internal medicine, Randomized controlled trial, Seroconversion and Immunogenicity in her study of Dengue vaccine.
The various areas that she examines in her Dengue fever study include Tetanus, B cell and Environmental health.
Her Vaccination study incorporates themes from Virus, Neutralizing antibody, Seroprevalence and Immunity.
Between 2018 and 2021, her most popular works were:
- Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response (35 citations)
- What is the prospect of a safe and effective dengue vaccine for travellers (20 citations)
- Pre-vaccination screening strategies for the use of the CYD-TDV dengue vaccine: A meeting report. (19 citations)
In her most recent research, the most cited papers focused on:
- Virus
- Immune system
- Antibody
Anna P. Durbin focuses on Dengue vaccine, Dengue fever, Vaccination, Epitope and Dengue virus.
Her Dengue vaccine research integrates issues from Clinical trial, Intention-to-treat analysis, Seroconversion and Intensive care medicine.
Her Dengue fever research incorporates themes from Seroprevalence, Tetanus and Environmental health.
Her Vaccination study necessitates a more in-depth grasp of Virology.
Her Epitope research also covers Antibody and Immunology studies.
She regularly ties together related areas like Viral envelope in her Dengue virus studies.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
